Clinical trial
Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171…
NCT00306891 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00306891 |
|---|---|
| Title | Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™) |
| Official title | Open-label, Randomised, Phase 2 Study in Patients With Advanced Solid Tumours to Determine Effect of Food Upon Pharmacokinetics of a Single Oral Dose of Cediranib (AZD2171, Recentin™), Followed by an Assessment of the Safety & Tolerability of Fixed and Individualised Daily Dosing |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | Cediranib, Cediranib 30 - 90 mg |
| Enrollment | 60 |
| Start date | Jun 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Mar 27, 2006 |
| Last update posted | Nov 1, 2012 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: